![Yannick Jacques](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Yannick Jacques is the founder and Chief Scientific Officer of Cytune Pharma SAS, which is founded in 2007.
He also held the position of Director-Cancer Research Center at the University of Nantes.
Postes actifs de Yannick Jacques
Sociétés | Poste | Début |
---|---|---|
Cytune Pharma SAS
![]() Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Fondateur | 15/11/2007 |
Anciens postes connus de Yannick Jacques
Sociétés | Poste | Fin |
---|---|---|
University of Nantes | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Cytune Pharma SAS
![]() Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |